Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia

In this work nasal powder formulations of thalidomide were designed and studied to be used by persons affected by hereditary hemorrhagic telangiectasia as a complementary anti-epistaxis therapy, with the goal of sustaining the effect obtained with thalidomide oral treatment after its discontinuation...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, G., Bortolotti, F., Chiapponi, V., Buttini, F., Sonvico, F., Invernizzi, R., Quaglia, F., Danesino, C., Pagella, F., Russo, P., Bettini, R., Colombo, P., Rossi, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier/North-Holland Biomedical Press 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120990/
https://www.ncbi.nlm.nih.gov/pubmed/27863666
http://dx.doi.org/10.1016/j.ijpharm.2016.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120990/
https://www.ncbi.nlm.nih.gov/pubmed/27863666
http://dx.doi.org/10.1016/j.ijpharm.2016.07.002

Ejemplares similares